Rechercher
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
Accounts of women identified as drinking at ‘high risk’ during pregnancy
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Webinaire sur la prévention de la toxicomanie chez les jeunes
L’International Society of Substance Use Professionals (ISSUP) Indonesia et l’Indonesia International Training and Treatment Centre (ITTC) ont organisé ensemble le deuxième webinaire sur la « Prévention de la toxicomanie chez les jeunes »...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA approuve une nouvelle option de traitement à la buprénorphine pour le trouble lié à l’utilisation d’opioïdes
Pour diffusion immédiate : 24 mai 2023
Aujourd’hui, la Food and Drug Administration (FDA) des États-Unis a approuvé l’injection sous-cutanée à libération prolongée de Brixadi (buprénorphine) pour traiter les troubles modérés à graves liés...
Covering Substance Use and Addiction Responsibly
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...
Stratégies de lutte contre la cocaïne et la méthamphétamine
Présentée par Richard Rawson, PhD, professeur émérite au Département de psychiatrie et de sciences biocomportementales de la faculté de médecine de l’UCLA et professeur de recherche à l’Université du Vermont, cette présentation a donné un...
Character Strengths and Recovery from Addiction
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
L’activation focale des récepteurs mu-opioïdes favorise la neuroinflammation et l’activation microgliale dans le système mésocorticolimbique : Altérations induites par la douleur inflammatoire
Abstrait
La microglie participe à la modulation de la signalisation de la douleur. Il est suggéré que l’activation de la microglie joue un rôle important dans les troubles affectifs liés à un dysfonctionnement du système...
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member